WT_1基因在白血病和骨髓增生异常综合征的表达及其意义
出处
《现代实用医学》
2004年第10期625-627,共3页
Modern Practical Medicine
参考文献17
-
1Ogawa H, Tsuboi A, Oji Y, et al. Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogenic bone marrow transplantation: importance of the monitoring of minimal residual disease by
-
2Cilloni D, Gottardi E, Messa F, et al. Significant correlation between the degree of WT1 expression and the International prognostic Scoring System Score in patients with Myelodysplastic Syndromes[J]. J Clin Oncol,2003,21 (10): 1988-1995.
-
3Wang ZY, Qiu QQ, Huang Let al. Products of alternatively soliced transcripts of the Wilms tumor suppressor gene,wtl,have altered DNA binding specificity and regulate transcfition in different ways[J]. Oncogene, 1995,10(3):415-22.
-
4Caricasole A, Duarte A, Larsson S,et al. RNA binding by the Wilms tumor suppressor zinc finger proteins[J].Proc Natl Acad Sci USA, 1996,(93):7562-7566.
-
5Cilloni D, Gottardi E, Fava M, et al. Usefulness of quantitative assegsment of the WT1 gene transcript as a marker for minimal residual disease detection[J]. Blood,2003,102(2):773-774.
-
6Tamaki H O,gawa H, Ohyashiki K, et al. The Wilms tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes[J]. Leukemia, 1999,13:393-399.
-
7Sako M,Ogawa H,Okamura J,et al. Abnormal expression of the Wilms' tumor gene WT1 in juvenile chronic myeloid leukemia and infantile monosomy 7 syndrome[J]. Leuk Res,1998,22(10):965-967.
-
8Menssen HD,Renkl HJ. Rieder H,et al. Distinction of eosinophilic leukaema from idiopathic hypereosinophilic syndrome by analysis of Wilms' tumour gene expression[J]. Br J Haematol, 1998,101(2):325-334.
-
9Elisseeva OA,Oka Y, Tsuboi A, et al.Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies[J].Blood,2002,99,3272-3279.
-
10Rosenfeld C, Cheever MA, Gaiger A.et al. WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies[J]. Leukemia, 2003,17(7): 1301-1312.
-
1何璐,周新科,洪健.肝细胞癌中Musashi2的表达及意义[J].广东医学,2013,34(20):3152-3154. 被引量：6
-
2汤迪,陶磊.MicroRNA在头颈部鳞状细胞癌中的研究进展[J].中国眼耳鼻喉科杂志,2015,15(2):135-137. 被引量：2
-
3沈秋丹（综述）,徐卫（审校）,李建勇（审校）.慢性淋巴细胞白血病微小残留病研究进展[J].国际检验医学杂志,2007,28(7):619-621.
-
4冯建华,徐晓军,汤永民.流式细胞仪检测儿童急性髓系白血病微小残留病的研究进展[J].中华儿科杂志,2013,51(3):231-234. 被引量：4
-
5肿瘤[J].中国中西医结合儿科学,2002(6):350-351.
-
6顾小锋,吴月.白血病微小残留病的检测[J].国外医学（儿科学分册）,1992,19(4):186-189.
-
7金润铭.儿童急性白血病微小残留病的检测及意义[J].中国实用儿科杂志,2002,17(6):339-342. 被引量：2
-
8杜春燕,于洁.流式细胞术检测儿童急性髓细胞白血病微小残留病研究进展[J].中国小儿血液与肿瘤杂志,2015,20(3):159-162.
-
9杜柏秋.应用荧光定量PCR检测急性白血病微小残留病的临床意义[J].中国实验诊断学,2011,15(4):702-703. 被引量：1
-
10陈洁,朱康儿.白血病微小残留病的研究进展[J].国外医学（内科学分册）,2004,31(6):238-241. 被引量：5
